Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders

Jori A. Leijdekkers, Helen L. Torrance, Nienke E. Schouten, Theodora C. van Tilborg, Simone C. Oudshoorn, Ben Willem J. Mol, Marinus J.C. Eijkemans, Frank J.M. Broekmans

Research output: Contribution to journalArticle

Abstract

In IVF/ICSI treatment, the FSH starting dose is often increased in predicted low responders from the belief that it improves the chance of having a baby by maximizing the number of retrieved oocytes. This intervention has been evaluated in several randomized controlled trials, and despite a slight increase in the number of oocytes-on average one to two more oocytes in the high versus standard dose group-no beneficial impact on the probability of a live birth has been demonstrated (risk difference, -0.02; 95% CI, -0.11 to 0.06). Still, many clinicians and researchers maintain a highly ingrained belief in 'the more oocytes, the better'. This is mainly based on cross-sectional studies, where the positive correlation between the number of retrieved oocytes and the probability of a live birth is interpreted as a direct causal relation. If the latter would be present, indeed, maximizing the oocyte number would benefit our patients. The current paper argues that the use of high FSH doses may not actually improve the probability of a live birth for predicted low responders undergoing IVF/ICSI treatment and exemplifies the flaws of directly using cross-sectional data to guide FSH dosing in clinical practice. Also, difficulties in the de-implementation of the increased FSH dosing strategy are discussed, which include the prioritization of intermediate outcomes (such as cycle cancellations) and the potential biases in the interpretation of study findings (such as confirmation or rescue bias).

Original languageEnglish
Pages (from-to)1954-1963
Number of pages10
JournalHuman reproduction (Oxford, England)
Volume35
Issue number9
Early online date15 Dec 2019
DOIs
Publication statusPublished - 1 Sep 2020

Keywords

  • FSH dosing
  • IVF/ICSI
  • live birth
  • oocyte number
  • predicted low responder

Fingerprint Dive into the research topics of 'Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders'. Together they form a unique fingerprint.

  • Cite this

    Leijdekkers, J. A., Torrance, H. L., Schouten, N. E., van Tilborg, T. C., Oudshoorn, S. C., Mol, B. W. J., Eijkemans, M. J. C., & Broekmans, F. J. M. (2020). Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders. Human reproduction (Oxford, England), 35(9), 1954-1963. https://doi.org/10.1093/humrep/dez184